Jirnal

Jirnal

Rivaroxaban Reduce Recurrent Limb Events in VOYAGER-PAD

Rivaroxaban Reduce Recurrent Limb Events in VOYAGER-PAD

After sufferers with peripheral artery disease endure decrease-extremity revascularization, they’re at high risk for predominant negative limb occasions, and original findings from a prespecified prognosis of knowledge from the VOYAGER-PAD trial describe that therapy with the negate-performing oral anticoagulant rivaroxaban…